in

Grünenthal is Recognized for its Strong Management of Environmental, Social and Governance (ESG) Risks

Leading global ESG ratings agency Sustainalytics notes Grünenthal is in the top five percent among its peers in the pharmaceutical subindustry Grünenthal is categorized as “medium risk”, placing it ahead of its key subindustry peers and in the same league as multinational companies like Pfizer and Roche Aachen, Germany, 7 April 2021 – Grünenthal, a global science-based pharmaceutical company, today announced that Sustainalytics, a Morningstar company and a globally-recognized provider of ESG research, ratings and… Source: RealWire Source Article

Written by HR Today

Financial services workers call for flexibility

Muslim nuclear engineer wins religious discrimination claim